ATE216889T1 - Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension - Google Patents
Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertensionInfo
- Publication number
- ATE216889T1 ATE216889T1 AT94119571T AT94119571T ATE216889T1 AT E216889 T1 ATE216889 T1 AT E216889T1 AT 94119571 T AT94119571 T AT 94119571T AT 94119571 T AT94119571 T AT 94119571T AT E216889 T1 ATE216889 T1 AT E216889T1
- Authority
- AT
- Austria
- Prior art keywords
- glaucoma
- treatment
- prostagrandin
- analogue
- hypertension
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 abstract 2
- 206010018307 Glaucoma and ocular hypertension Diseases 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16774793A | 1993-12-15 | 1993-12-15 | |
US08/167,470 US5721273A (en) | 1993-12-15 | 1993-12-15 | Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension |
US31667294A | 1994-09-30 | 1994-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE216889T1 true ATE216889T1 (de) | 2002-05-15 |
Family
ID=27389393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94119571T ATE216889T1 (de) | 1993-12-15 | 1994-12-10 | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP0667160B1 (de) |
AT (1) | ATE216889T1 (de) |
AU (1) | AU687906B2 (de) |
DE (1) | DE69430521D1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US6169111B1 (en) | 1995-06-07 | 2001-01-02 | Alcon Laboratories, Inc. | Conformationally rigid aryl prostaglandins for use in glaucoma therapy |
US5814660A (en) * | 1995-12-22 | 1998-09-29 | Alcon Laboratories, Inc. | 9-oxa prostaglandin analogs as ocular hypotensives |
EP0869794B1 (de) * | 1995-12-22 | 2004-08-11 | Alcon Laboratories, Inc. | Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel |
US5866602A (en) * | 1995-12-22 | 1999-02-02 | Alcon Laboratories, Inc. | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
JP2001504100A (ja) * | 1996-11-01 | 2001-03-27 | アルコン・ラボラトリーズ・インコーポレーテッド | 緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用 |
AU5436198A (en) * | 1996-11-12 | 1998-06-03 | Alcon Laboratories, Inc. | 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
CZ20023092A3 (cs) * | 2000-03-16 | 2003-05-14 | Sucampo Ag | Farmaceutický prostředek vhodný pro dlouhodobou léčbu nebo profylaktické ošetření oční hypertenze a glakomu |
US6458836B1 (en) | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
AR036276A1 (es) * | 2001-08-23 | 2004-08-25 | Sucampo Ag | Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma |
AU2003215820A1 (en) * | 2002-03-28 | 2003-10-13 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
MX2018003462A (es) | 2015-09-22 | 2018-09-06 | Graybug Vision Inc | Compuestos y composiciones para el tratamiento de trastornos oculares. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
DE3510978A1 (de) * | 1985-03-22 | 1986-09-25 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
CA1322197C (en) * | 1987-07-17 | 1993-09-14 | Bernd Buchmann | 9-halogen-(z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents |
DE4024347A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
DE4036140A1 (de) * | 1990-11-09 | 1992-05-14 | Schering Ag | 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE4229053A1 (de) * | 1992-08-31 | 1994-03-03 | Schering Ag | Verwendung von Estern und Amiden von 9-Chlor-Prostaglandinen für die Herstellung von Arzneimitteln zur Förderung der Hautdurchblutung |
WO1994005631A1 (de) * | 1992-08-31 | 1994-03-17 | Schering Aktiengesellschaft | 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln |
-
1994
- 1994-11-30 AU AU79138/94A patent/AU687906B2/en not_active Ceased
- 1994-12-10 EP EP94119571A patent/EP0667160B1/de not_active Expired - Lifetime
- 1994-12-10 EP EP00204408A patent/EP1088816A2/de not_active Withdrawn
- 1994-12-10 DE DE69430521T patent/DE69430521D1/de not_active Expired - Lifetime
- 1994-12-10 AT AT94119571T patent/ATE216889T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1088816A2 (de) | 2001-04-04 |
EP0667160B1 (de) | 2002-05-02 |
EP0667160A3 (de) | 1995-11-15 |
DE69430521D1 (de) | 2002-06-06 |
AU7913894A (en) | 1995-06-22 |
EP0667160A2 (de) | 1995-08-16 |
AU687906B2 (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
DE68929563D1 (de) | Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension | |
ATE286880T2 (de) | Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension | |
BR9813767A (pt) | Processo e composição para tratar glaucoma de glc1a | |
DE69634414D1 (de) | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie | |
DE60334134D1 (de) | Ungsmethode von erhöhtem augeninnendruck und glaukom | |
ATE216889T1 (de) | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension | |
DE3872701D1 (de) | Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck. | |
ATE223200T1 (de) | Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel | |
ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
ATE117208T1 (de) | Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |